On the contrary, the so-called Icelandic mutation in APP [11], which alters one amino acid at the BACE1 cleavage site of APP, reducing the ability of BACE1 to cleave APP by about 30% [12], is strongly protective against AD. The gene discussed is BACE1; the disease is Alzheimer disease.